<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Morphology</journal-id><journal-title-group><journal-title xml:lang="en">Morphology</journal-title><trans-title-group xml:lang="ru"><trans-title>Морфология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1026-3543</issn><issn publication-format="electronic">2949-2556</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">646329</article-id><article-id pub-id-type="doi">10.17816/morph.646329</article-id><article-id pub-id-type="edn">YSKSPE</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original Study Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Morphometric parameters of keratinocyte proliferation and apoptosis following ascorbic acid administration in radiation-induced skin injury</article-title><trans-title-group xml:lang="ru"><trans-title>Морфометрические показатели пролиферации и апоптоза кератиноцитов после введения аскорбиновой кислоты при радиационно-индуцированном повреждении кожи</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>电离辐射诱导皮肤损伤模型中注射抗坏血酸后角质形成细胞增殖与凋亡的形态计量学指标</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8447-2600</contrib-id><contrib-id contrib-id-type="spin">5157-0177</contrib-id><name-alternatives><name xml:lang="en"><surname>Demyashkin</surname><given-names>Grigory A.</given-names></name><name xml:lang="ru"><surname>Демяшкин</surname><given-names>Григорий Александрович</given-names></name><name xml:lang="zh"><surname>Demyashkin</surname><given-names>Grigory A.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Sci. (Medicine)</p></bio><bio xml:lang="ru"><p>д-р мед. наук</p></bio><bio xml:lang="zh"><p>Dr. Sci. (Medicine)</p></bio><email>dr.dga@mail.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6235-1020</contrib-id><contrib-id contrib-id-type="spin">9485-7722</contrib-id><name-alternatives><name xml:lang="en"><surname>Vadyukhin</surname><given-names>Matvey A.</given-names></name><name xml:lang="ru"><surname>Вадюхин</surname><given-names>Матвей Анатольевич</given-names></name><name xml:lang="zh"><surname>Vadyukhin</surname><given-names>Matvey A.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>vma20@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4619-7385</contrib-id><contrib-id contrib-id-type="spin">4320-6507</contrib-id><name-alternatives><name xml:lang="en"><surname>Marukyan</surname><given-names>Anna K.</given-names></name><name xml:lang="ru"><surname>Марукян</surname><given-names>Анна Хачиковна</given-names></name><name xml:lang="zh"><surname>Marukyan</surname><given-names>Anna K.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>Marukyan87@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8606-8716</contrib-id><contrib-id contrib-id-type="spin">7742-1420</contrib-id><name-alternatives><name xml:lang="en"><surname>Saakyan</surname><given-names>Susanna V.</given-names></name><name xml:lang="ru"><surname>Саакян</surname><given-names>Сюзанна Вачагановна</given-names></name><name xml:lang="zh"><surname>Saakyan</surname><given-names>Susanna V.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>drsaakyan@icloud.com</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9833-3433</contrib-id><contrib-id contrib-id-type="spin">8221-3003</contrib-id><name-alternatives><name xml:lang="en"><surname>Karakaeva</surname><given-names>Elza B.</given-names></name><name xml:lang="ru"><surname>Каракаева</surname><given-names>Эльза Бахты-Гереевна</given-names></name><name xml:lang="zh"><surname>Karakaeva</surname><given-names>Elza B.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>kchr09@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0128-4538</contrib-id><contrib-id contrib-id-type="spin">8153-5789</contrib-id><name-alternatives><name xml:lang="en"><surname>Koryakin</surname><given-names>Sergey N.</given-names></name><name xml:lang="ru"><surname>Корякин</surname><given-names>Сергей Николаевич</given-names></name><name xml:lang="zh"><surname>Koryakin</surname><given-names>Sergey N.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Biology)</p></bio><bio xml:lang="ru"><p>канд. биол. наук</p></bio><bio xml:lang="zh"><p>Cand. Sci. (Biology)</p></bio><email>korsernic@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2544-7696</contrib-id><contrib-id contrib-id-type="spin">5321-1246</contrib-id><name-alternatives><name xml:lang="en"><surname>Shapovalova</surname><given-names>Elena Y.</given-names></name><name xml:lang="ru"><surname>Шаповалова</surname><given-names>Елена Юрьевна</given-names></name><name xml:lang="zh"><surname>Shapovalova</surname><given-names>Elena Y.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Sci. (Medicine), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><bio xml:lang="zh"><p>Dr. Sci. (Medicine), Professor</p></bio><email>shapovalova_l@mail.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-9370-3600</contrib-id><name-alternatives><name xml:lang="en"><surname>Kantorovich</surname><given-names>Alexey A.</given-names></name><name xml:lang="ru"><surname>Канторович</surname><given-names>Алексей Александрович</given-names></name><name xml:lang="zh"><surname>Kantorovich</surname><given-names>Alexey A.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>w.q.989@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-1787-5910</contrib-id><name-alternatives><name xml:lang="en"><surname>Andrievskikh</surname><given-names>Anastasiia S.</given-names></name><name xml:lang="ru"><surname>Андриевских</surname><given-names>Анастасия Сергеевна</given-names></name><name xml:lang="zh"><surname>Andrievskikh</surname><given-names>Anastasiia S.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>Andrievskikh2002@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">National Medical Research Radiological Center of the Ministry of Health of the Russian Federation</institution></aff><aff><institution xml:lang="ru">Национальный медицинский исследовательский центр радиологии Минздрава России</institution></aff><aff><institution xml:lang="zh">National Medical Research Radiological Center of the Ministry of Health of the Russian Federation</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">The First Sechenov Moscow State Medical University</institution></aff><aff><institution xml:lang="ru">Первый Московский государственный медицинский университет им. И.М. Сеченова</institution></aff><aff><institution xml:lang="zh">The First Sechenov Moscow State Medical University</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">V.I. Vernadsky Crimean Federal University</institution></aff><aff><institution xml:lang="ru">Крымский федеральный университет им. В.И. Вернадского</institution></aff><aff><institution xml:lang="zh">V.I. Vernadsky Crimean Federal University</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2025-06-01" publication-format="electronic"><day>01</day><month>06</month><year>2025</year></pub-date><pub-date date-type="pub" iso-8601-date="2025-08-06" publication-format="electronic"><day>06</day><month>08</month><year>2025</year></pub-date><volume>163</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><issue-title xml:lang="zh"/><fpage>200</fpage><lpage>209</lpage><history><date date-type="received" iso-8601-date="2025-01-17"><day>17</day><month>01</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-03-14"><day>14</day><month>03</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, Эко-Вектор</copyright-statement><copyright-statement xml:lang="zh">Copyright ©; 2025,</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2028-08-06"/></permissions><self-uri xlink:href="https://j-morphology.com/1026-3543/article/view/646329">https://j-morphology.com/1026-3543/article/view/646329</self-uri><abstract xml:lang="en"><p><bold>BACKGROUND:</bold><italic> </italic>Available publications describe the features of radiation-induced skin injury and fibrosis caused by various types of ionizing radiation. Compared with other forms of ionizing radiation, electrons exhibit relatively low cytotoxicity to healthy organs; however, their side effects remain insufficiently explored. One of the key objectives is to develop protective strategies for the epidermis and dermis against electron-induced cytotoxicity during the treatment of malignant tumors and percutaneous tumor exposure.</p> <p><bold>AIM:</bold><italic> </italic>The work aimed to perform a morphometric assessment of keratinocyte proliferation and apoptosis following ascorbic acid administration in an experimental model of radiation-induced skin injury.</p> <p><bold>METHODS:</bold><italic> </italic>A single-center, prospective, controlled study was conducted. The study object was skin fragments from the outer surface of the thigh of male Wistar rats (aged 9–10 weeks, weighing 220 ± 20 g). Animals (<italic>n</italic> = 50) were randomly divided into four experimental groups: group 1, controls (<italic>n</italic> = 20); group 2, local electron irradiation at a dose of 40 Gy (<italic>n</italic> = 10); group 3, administration of ascorbic acid (intraperitoneally, 50 mg/kg) prior to local electron irradiation at a dose of 40 Gy (<italic>n</italic> = 10); group 4, administration of ascorbic acid without irradiation (<italic>n</italic> = 10). After 10 days, skin samples from the irradiated area were harvested for histological and immunohistochemical analysis (using Ki-67 and caspase-3 antibodies).</p> <p><bold>RESULTS:</bold><italic> </italic>Ten days after local electron irradiation with the NOVAC-11 linear accelerator (Italy) at a dose of 40 Gy, the exposed skin areas showed signs of radiation-induced injury: moist desquamation, edema, partial desquamation of the basal epidermal layer, formation of microcavities at the dermoepidermal junction, damage to most sebaceous glands, and imbalance in malondialdehyde content and superoxide dismutase activity. Results of Ki-67 and caspase-3 expression analysis revealed reduced keratinocyte proliferative activity and increased apoptosis. However, in animals pretreated with ascorbic acid, the levels of keratinocyte proliferation and apoptosis, as well as epidermal thickness, were comparable to those in the control group.</p> <p><bold>CONCLUSION:</bold> The findings demonstrate the high radioprotective efficacy of ascorbic acid for the epidermis under local electron irradiation at a dose of 40 Gy. Ascorbic acid prevents radiation-induced apoptotic death of keratinocytes by reducing oxidative damage caused by free radicals and by inducing superoxide dismutase expression.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование</bold>. В литературе описаны признаки радиационно-индуцированного повреждения и фиброза кожи после воздействия разных видов ионизирующего излучения. Электроны характеризуются относительно низкой цитотоксичностью в отношении здоровых органов по сравнению с другими видами ионизирующего излучения, однако их побочные эффекты до конца не изучены. Важной задачей является разработка способов протекции эпидермиса и дермы от цитотоксического действия электронов при проведении лечения злокачественных новообразований и при перкутанном воздействии на опухоли.</p> <p><bold>Цель</bold> — провести морфометрическую оценку пролиферации и апоптоза кератиноцитов после введения аскорбиновой кислоты в экспериментальной модели радиационно-индуцированного повреждения кожи.</p> <p><bold>Методы</bold>. Проведено одноцентровое проспективное контролируемое исследование. Объект исследования — фрагменты кожи наружной поверхности бедра самцов крыс линии Вистар (возраст 9–10 недель, вес 220±20 г). Животных (<italic>n</italic>=50) случайным образом разделили на четыре экспериментальные группы: I — контрольная (<italic>n</italic>=20); II — локальное облучение электронами в дозе 40 Гр (<italic>n</italic>=10); III — введение аскорбиновой кислоты (интраперитонеально в дозе 50 мг/ кг) перед локальным облучением электронами в дозе 40 Гр (<italic>n</italic>=10); IV — введение аскорбиновой кислоты без облучения (<italic>n</italic>=10). Через 10 суток фрагменты кожи из области облучения фиксировали для последующего проведения гистологического и иммуногистохимического (с использованием антител к Ki-67 и каспазе-3) исследований.</p> <p><bold>Результаты</bold>. Спустя 10 суток после облучения электронами на линейном акселераторе NOVAC-11 (Италия) в дозе 40 Гр в зоне воздействия наблюдаются признаки радиационно-индуцированного повреждения кожи: влажное шелушение, отёк, частичная десквамация базального слоя эпидермиса, образование микрополостей в области дермоэпидермального соединения, поражение большинства сальных желёз, а также дисбаланс в содержании малонового диальдегида и активности супероксиддисмутазы. Результаты оценки экспрессии Ki-67 и каспазы-3 свидетельствуют о снижении пролиферативной активности и об индукции апоптоза в кератиноцитах. Однако после предлучевого введения аскорбиновой кислоты количественные показатели пролиферации и апоптоза кератиноцитов, а также толщина эпидермиса близки к значениям в контрольной группе.</p> <p><bold>Заключение</bold>. Результаты исследования свидетельствуют о высокой радиопротективной эффективности аскорбиновой кислоты в отношении эпидермиса при локальном облучении электронами в дозе 40 Гр. Аскорбиновая кислота предотвращает радиационно-индуцированную апоптотическую гибель кератиноцитов путём снижения степени их оксидантного повреждения свободными радикалами, а также за счёт индукции экспрессии супероксиддисмутазы.</p></trans-abstract><trans-abstract xml:lang="zh"><p>论证。文献中已报道多种电离辐射类型对皮肤造成的辐射性损伤和纤维化表现。与其他类型电离辐射相比，电子束对健康器官的细胞毒性相对较低，但其副作用尚未被充分研究。在恶性肿瘤治疗和经皮照射过程中，保护表皮和真皮免受电子束细胞毒性影响仍是重要任务。</p> <p>目的：在电离辐射诱导皮肤损伤的实验模型中，评估注射抗坏血酸后角质形成细胞增殖与凋亡的形态计量学特征。</p> <p>方法。本研究为单中心前瞻性对照实验。研究对象为Wistar雄性大鼠（9–10周龄，体重220±20克）股外侧皮肤组织的切片。动物（n=50）随机分为四个实验组：I组 — 对照组（n=20）；II组 — 局部电子束照射，剂量为40 Gy（n=10）；III组 — 照射前腹腔注射抗坏血酸50 mg/kg，随后接受40 Gy电子束照射（n=10）；IV组 — 单独注射抗坏血酸，未进行照射（n=10）。于照射后第10天采集照射区域皮肤样本，进行组织学与免疫组织化学检测（使用Ki-67和caspase-3抗体）。</p> <p>结果。在使用NOVAC-11（意大利）直线加速器进行40 Gy电子束照射10天后，照射区域出现典型的辐射性皮肤损伤征象，包括湿性脱屑、水肿、基底层部分脱落、真表皮连接区形成微小空腔、大部分皮脂腺受损，以及丙二醛含量与超氧化物歧化酶活性失衡。Ki-67和caspase-3的表达结果显示角质形成细胞的增殖能力降低，凋亡增强。然而，在照射前给予抗坏血酸处理的动物中，角质形成细胞的增殖与凋亡指标以及表皮厚度均接近对照组水平。</p> <p>结论。研究结果表明，在40 Gy局部电子束照射条件下，抗坏血酸对表皮具有较高的辐射防护效能。抗坏血酸通过减少自由基介导的氧化损伤，并诱导超氧化物歧化酶的表达，从而防止辐射诱导的角质形成细胞凋亡。</p></trans-abstract><kwd-group xml:lang="en"><kwd>keratinocytes</kwd><kwd>skin</kwd><kwd>radiation-induced injury</kwd><kwd>electron irradiation</kwd><kwd>apoptosis</kwd><kwd>proliferation</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>кератиноциты</kwd><kwd>кожа</kwd><kwd>радиационно-индуцированное повреждение</kwd><kwd>облучение электронами</kwd><kwd>апоптоз</kwd><kwd>пролиферация</kwd></kwd-group><kwd-group xml:lang="zh"><kwd>角质形成细胞</kwd><kwd>皮肤</kwd><kwd>辐射性损伤</kwd><kwd>电子束照射</kwd><kwd>细胞凋亡</kwd><kwd>细胞增殖</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Voshart DC, Wiedemann J, van Luijk P, Barazzuol L. Regional responses in radiation-induced normal tissue damage. Cancers (Basel). 2021;13(3):367. doi: 10.3390/cancers13030367 EDN: NIYBVY</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Reisz JA, Bansal N, Qian J, et al. Effects of ionizing radiation on biological molecules--mechanisms of damage and emerging methods of detection. Antioxid Redox Signal. 2014;21(2):260–292. doi: 10.1089/ars.2013.5489 EDN: UTDMBT</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Wang L, Lin B, Zhai M, et al. Deteriorative Effects of radiation injury combined with skin wounding in a mouse model. Toxics. 2022;10(12):785. doi: 10.3390/toxics10120785 EDN: DBGZGI</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Demyashkin G, Shapovalova Y, Marukyan A, et al. Immunohistochemical and histochemical analysis of the rat skin after local electron irradiation. Open Vet J. 2023;13(12):1570–1582. doi: 10.5455/OVJ.2023.v13.i12.7 EDN: YFSLDE</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Wieland LS, Moffet I, Shade S, et al. Risks and benefits of antioxidant dietary supplement use during cancer treatment: protocol for a scoping review. BMJ Open. 2021;11(4):e047200. doi: 10.1136/bmjopen-2020-047200 EDN: DTTCEQ</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Attia AA, Hamad HA, Fawzy MA, Saleh SR. The prophylactic effect of vitamin C and vitamin B12 against ultraviolet-C-induced hepatotoxicity in male rats. Molecules. 2023;28(11):4302. doi: 10.3390/molecules28114302 EDN: FYZPGK</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Sato T, Kinoshita M, Yamamoto T, et al. Treatment of irradiated mice with high-dose ascorbic acid reduced lethality. PLoS One. 2015;10(2):e0117020. doi: 10.1371/journal.pone.0117020</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Demyashkin GA, Atyakshin DA, Yakimenko VA, et al. Characteristics of proliferation and apoptosis of hepatocytes after administration of ascorbic acid in a model of radiation hepatitis. Morphology. 2023;161(3):31–38. (In Russ.) doi: 10.17816/morph.624714 EDN: LDQCJS</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>King M, Joseph S, Albert A, et al. Use of Amifostine for cytoprotection during radiation therapy: A review. Oncology. 2020;98(2):61–80. doi: 10.1159/000502979</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Kawashima S, Funakoshi T, Sato Y, et al. Protective effect of pre- and post-vitamin C treatments on UVB-irradiation-induced skin damage. Sci Rep. 2018;8(1):16199. doi: 10.1038/s41598-018-34530-4 EDN: ONLVLU</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Ravetti S, Clemente C, Brignone S, et al. Ascorbic acid in skin health. Cosmetics. 2019;6(4):58. doi: 10.3390/cosmetics6040058</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31(5):1341–1346. doi: 10.1016/0360-3016(95)00060-C EDN: APLAHB</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Williams JP, Newhauser W. Normal tissue damage: its importance, history and challenges for the future. Br J Radiol. 2019;92(1093):20180048. doi: 10.1259/bjr.20180048 EDN: WXTPZI</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Zhao H, Zhuang Y, Li R, et al. Effects of different doses of X-ray irradiation on cell apoptosis, cell cycle, DNA damage repair and glycolysis in HeLa cells. Oncol Lett. 2019;17(1):42–54. doi: 10.3892/ol.2018.9566</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Nuszkiewicz J, Woźniak A, Szewczyk-Golec K. Ionizing radiation as a source of oxidative stress-the protective role of melatonin and vitamin D. Int J Mol Sci. 2020;21(16):5804. doi: 10.3390/ijms21165804 EDN: KOENZI</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Jiao Y, Cao F, Liu H. Radiation-induced cell death and its mechanisms. Health Phys. 2022;123(5):376–386. doi: 10.1097/HP.0000000000001601 EDN: SAYLYY</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Bontempo PSM, Ciol MA, Menêses AG, et al. Acute radiodermatitis in cancer patients: incidence and severity estimates. Rev Esc Enferm USP. 2021;55:e03676. doi: 10.1590/S1980-220X2019021703676 EDN: JAVVIL</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Bromberger L, Heise B, Felbermayer K, et al. Radiation-induced alterations in multi-layered, in-vitro skin models detected by optical coherence tomography and histological methods. PLoS One. 2023;18(3):e0281662. doi: 10.1371/journal.pone.0281662 EDN: ZXDUWC</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Kim JS, Park SH, Jang WS, et al. Gamma-ray-induced skin injury in the mini-pig: Effects of irradiation exposure on cyclooxygenase-2 expression in the skin. J Radiat Prot Res. 2015;40(1):65–72. doi: 10.14407/jrp.2015.40.1.065</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Kim JS, Jang H, Bae MJ, et al. Comparison of skin injury induced by β- and γ-irradiation in the minipig model. J Radiat Prot Res. 2017;42(4):189–196. doi: 10.14407/jrpr.2017.42.4.189</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Calvo FA, Serrano J, Cambeiro M, et al. Intra-operative electron radiation therapy: An update of the evidence collected in 40 years to search for models for Electron-FLASH studies. Cancers (Basel). 2022;14(15):3693. doi: 10.3390/cancers14153693 EDN: CQBIEW</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Gęgotek A, Skrzydlewska E. Antioxidative and anti-inflammatory activity of ascorbic acid. Antioxidants (Basel). 2022;11(10):1993. doi: 10.3390/antiox11101993 EDN: BZOSDJ</mixed-citation></ref></ref-list></back></article>
